Production (Stage)
Coya Therapeutics, Inc.
COYA
$5.45
-$0.18-3.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.14M | -14.88M | -10.70M | -10.10M | -10.30M |
| Total Depreciation and Amortization | 27.20K | 27.20K | 27.20K | 27.20K | 27.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.31M | 2.69M | 2.33M | 1.82M | 1.70M |
| Change in Net Operating Assets | -1.46M | 1.88M | -1.78M | 1.38M | 3.40M |
| Cash from Operations | -15.26M | -10.29M | -10.12M | -6.87M | -5.18M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -25.00K | -218.20K | -218.20K | -568.20K |
| Cash from Investing | 0.00 | -25.00K | -218.20K | -218.20K | -568.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.86M | 16.22M | 30.70M | 30.70M | 25.55M |
| Repurchase of Common Stock | -56.30K | -56.30K | -56.30K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -131.90K | -131.90K | -131.90K | -131.90K |
| Cash from Financing | 14.80M | 16.03M | 30.51M | 30.57M | 25.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -458.70K | 5.71M | 20.17M | 23.47M | 19.67M |